Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q212171> ?p ?o }
Showing triples 1 to 96 of
96
with 100 triples per page.
- Q212171 subject Q7482753.
- Q212171 subject Q8872471.
- Q212171 subject Q8873325.
- Q212171 abstract "Rizatriptan (trade name Maxalt) is a 5-HT1 receptor agonist of the triptan class of drugs developed by Merck & Co. for the treatment of migraine headaches. It is available in strengths of 5 and 10 mg as tablets and orally disintegrating tablets (Maxalt-MLT).Maxalt obtained approval by the United States Food and Drug Administration (FDA) on June 29, 1998. It is a second-generation triptan.Rizatriptan is available only by prescription in Australia, Finland, the United States, Canada and New Zealand. Similarly, it is classed as a POM (Prescription Only Medicine) in the United Kingdom, Italy (as Rizaliv), France, Israel (as Rizalt), The Netherlands, Croatia and Spain (as Maxalt).".
- Q212171 atcPrefix "N02".
- Q212171 atcSuffix "CC04".
- Q212171 bioavailability "45.0".
- Q212171 casNumber "145202-66-0".
- Q212171 chEBI "48273".
- Q212171 drugbank "DB00953".
- Q212171 fdaUniiCode "WR978S7QHH".
- Q212171 iupacName "N,N-dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine".
- Q212171 pubchem "5078".
- Q212171 thumbnail Rizatriptan.svg?width=300.
- Q212171 wikiPageExternalLink www.maxalt.com.
- Q212171 wikiPageWikiLink Q101991.
- Q212171 wikiPageWikiLink Q1067506.
- Q212171 wikiPageWikiLink Q11068.
- Q212171 wikiPageWikiLink Q1123260.
- Q212171 wikiPageWikiLink Q114085.
- Q212171 wikiPageWikiLink Q12140.
- Q212171 wikiPageWikiLink Q12152.
- Q212171 wikiPageWikiLink Q133823.
- Q212171 wikiPageWikiLink Q13400765.
- Q212171 wikiPageWikiLink Q1410769.
- Q212171 wikiPageWikiLink Q142.
- Q212171 wikiPageWikiLink Q145.
- Q212171 wikiPageWikiLink Q16.
- Q212171 wikiPageWikiLink Q166907.
- Q212171 wikiPageWikiLink Q180007.
- Q212171 wikiPageWikiLink Q18027423.
- Q212171 wikiPageWikiLink Q18027426.
- Q212171 wikiPageWikiLink Q183344.
- Q212171 wikiPageWikiLink Q188008.
- Q212171 wikiPageWikiLink Q189763.
- Q212171 wikiPageWikiLink Q192309.
- Q212171 wikiPageWikiLink Q204711.
- Q212171 wikiPageWikiLink Q209583.
- Q212171 wikiPageWikiLink Q218820.
- Q212171 wikiPageWikiLink Q224.
- Q212171 wikiPageWikiLink Q2434711.
- Q212171 wikiPageWikiLink Q247489.
- Q212171 wikiPageWikiLink Q275419.
- Q212171 wikiPageWikiLink Q281289.
- Q212171 wikiPageWikiLink Q29.
- Q212171 wikiPageWikiLink Q30.
- Q212171 wikiPageWikiLink Q33.
- Q212171 wikiPageWikiLink Q3355478.
- Q212171 wikiPageWikiLink Q3503092.
- Q212171 wikiPageWikiLink Q38.
- Q212171 wikiPageWikiLink Q389934.
- Q212171 wikiPageWikiLink Q408.
- Q212171 wikiPageWikiLink Q40878.
- Q212171 wikiPageWikiLink Q40924.
- Q212171 wikiPageWikiLink Q410867.
- Q212171 wikiPageWikiLink Q410954.
- Q212171 wikiPageWikiLink Q416978.
- Q212171 wikiPageWikiLink Q41861.
- Q212171 wikiPageWikiLink Q419432.
- Q212171 wikiPageWikiLink Q423866.
- Q212171 wikiPageWikiLink Q42982.
- Q212171 wikiPageWikiLink Q474959.
- Q212171 wikiPageWikiLink Q496.
- Q212171 wikiPageWikiLink Q497232.
- Q212171 wikiPageWikiLink Q55.
- Q212171 wikiPageWikiLink Q5958765.
- Q212171 wikiPageWikiLink Q616181.
- Q212171 wikiPageWikiLink Q6431240.
- Q212171 wikiPageWikiLink Q664.
- Q212171 wikiPageWikiLink Q739481.
- Q212171 wikiPageWikiLink Q7482753.
- Q212171 wikiPageWikiLink Q753583.
- Q212171 wikiPageWikiLink Q769220.
- Q212171 wikiPageWikiLink Q7916887.
- Q212171 wikiPageWikiLink Q801.
- Q212171 wikiPageWikiLink Q844935.
- Q212171 wikiPageWikiLink Q86.
- Q212171 wikiPageWikiLink Q8872471.
- Q212171 wikiPageWikiLink Q8873325.
- Q212171 atcPrefix "N02".
- Q212171 atcSuffix "CC04".
- Q212171 bioavailability "45.0".
- Q212171 casNumber "145202".
- Q212171 chebi "48273".
- Q212171 drugbank "DB00953".
- Q212171 iupacName "N,N-dimethyl-2-[5--1H-indol-3-yl]ethanamine".
- Q212171 pubchem "5078".
- Q212171 unii "WR978S7QHH".
- Q212171 type ChemicalSubstance.
- Q212171 type Drug.
- Q212171 type ChemicalObject.
- Q212171 type Thing.
- Q212171 type Q8386.
- Q212171 comment "Rizatriptan (trade name Maxalt) is a 5-HT1 receptor agonist of the triptan class of drugs developed by Merck & Co. for the treatment of migraine headaches. It is available in strengths of 5 and 10 mg as tablets and orally disintegrating tablets (Maxalt-MLT).Maxalt obtained approval by the United States Food and Drug Administration (FDA) on June 29, 1998.".
- Q212171 label "Rizatriptan".
- Q212171 depiction Rizatriptan.svg.